Evaluation of two commercially available cannabidiol formulations for use in electronic cigarettes

Frontiers in Pharmacology

Volumn 7, Issue AUG, 2016, Pages

  Peace, Michelle R ^a   Butler, Karen E ^a   Wolf, Carl E ^a   Poklis, Justin L ^a   Poklis, Alphonse ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cannabidiol; DART MS; E liquids; Electronic cigarettes; HPLC MS MS; Vaping

Indexed keywords

6 METHYLCOUMARIN; ACETAL DERIVATIVE; ANTHRANILIC ACID DERIVATIVE; BENZALDEHYDE DERIVATIVE; BENZALDEHYDE PG ACETAL; CANNABIDIOL; DIMETHYL ANTHRANILATE; DIMETICONE; ETHYLMALTOL; GAMMA DECALACTONE; GAMMA NONALACTONE; HELIOTROPIN PG ACETAL; LACTONE DERIVATIVE; UNCLASSIFIED DRUG; VANILLIN;

ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ELECTRONIC CIGARETTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; MOLECULAR WEIGHT; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

EID: 84988723062     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00279     Document Type: Article

References (34)

1. Bao, M., Joza, P., Ricket, W. S., and Lauterback, J. H. (2010). An improved headspace solid-phase microextraction method for the analysis of free-base nicotine in particulate phase of mainstream cigarette smoke. Anal. Chim. Acta 663, 49-54. doi: 10.1016/j.aca.2010.01.036
2. Bekki, K., Uchiyama, S., Ohta, K., Inaba, Y., Nakagome, H., and Kunugita, N. (2014). Carbonyl compounds generated from electronic cigarettes. Int. J. Environ. Res. Public Health 11, 11192-11200. doi: 10.3390/ijerph111111192
3. Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., et al. (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35, 764-774. doi: 10.1038/npp.2009.184
4. Breland, A., Soule, E., Lopez, A., Ramôa, C., El-Hellani, A., and Eissenberg, T. (2016). Electronic cigarettes: what are they, and what do they do? Ann. N. Y. Acad Sci. doi: 10.1111/nyas.12977 [Epub ahead of print].
5. Brenneisen, R. (2007). "Chemistry and analysis of phytocannabinoids and other cannabis constituents," in Marijuana and the Cannabinoids, ed. M. Elsohly (Totowa, NJ: Human Press), 17-51.
6. Cloud 9 Hemp (2015). Cloud 9 Hemp," Cloud9hemp. com, Last Modified. Available at: https://cloud9hemp.com/(accessed May 10, 2016).
7. Etter, J. F., Zather, E., and Svensson, S. (2013). Analysis of refill liquids for electronic cigarettes. Addiction 108, 1671-1679. doi: 10.1111/add.12235
8. Fischer, B., Kuganesan, S., Gallassi, A., Malcher-Lopes, R., van den Brink, W., and Wood, E. (2015). Addressing the stimulant treatment gap: a call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use. Int. J. Drug Policy 26, 1177-1182. doi: 10.1016/j.drugpo.2015.09.005
9. Flora, J. W., Meruva, N., Huang, C. B., Wilkinson, C. T., Ballentine, R., Smith, D. C., et al. (2016). Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosols. Regul. Toxicol. Pharmacol. 74, 1-11. doi: 10.1016/j.yrtph.2015.11.009
10. Friedman, D., and Devinsky, O. (2015). Cannabinoids in the treatment of epilepsy. N. Engl. J. Med. 373, 1048-1058. doi: 10.1056/NEJMra1407304
11. Goniewicz, M. L., Hajek, P., and McRobbie, H. (2014). Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 109, 500-507. doi: 10.1111/add.12410
12. Goniewicz, M. L., Kuma, T., Gawron, M., Knysak, J., and Kosmider, L. (2013). Nicotine levels in electronic cigarettes. Nicotine Tob. Res. 15, 158-166. doi: 10.1093/ntr/nts103
13. Isodiol. (2016). "Disclaimer," Isodiol.com, Last Modified. Available at: http://www.isodiol.com/#!disclaimer/oztke
14. Jensen, R. P., Luo, W., Pankow, J. F., Strongin, R. M., and Peyton, D. H. (2015). Hidden formaldehyde in e-cigarette aerosols. N. Engl. J. Med. 372, 392-394. doi: 10.1056/NEJMc1413069
15. Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R., and Fallon, M. T. (2010). Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J. Pain Symptom Manage. 39, 167-179. doi: 10.1016/j.jpainsymman.2009.06.008
16. Kavvalakis, M. P., Stivaktakis, P. D., Tzatzarakis, M. N., Kouretas, D., Liesivuori, J., Alegakis, A. K., et al. (2015). Multicomponent analysis of replacement liquids of electronic cigarettes using chromatographic techniques. J. Anal. Toxicol. 39, 262-269. doi: 10.1093/jat/bkv002
17. Kosmider, L., Sobczak, A., Fik, M., Knysak, J., Zaciera, M., Kurek, J., et al. (2014). Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob. Res. 16, 1319-1326. doi: 10.1093/ntr/ntu078
18. Lisko, J. G., Tran, H., Stanfill, S. B., Blount, B. C., and Watson, C. H. (2015). Chemical composition and evaluation of nicotine, tobacco alkaloids, ph, and selected flavors in e-cigarette cartridges and refill solutions. Nicotine Tob. Res. 17, 1270-1278. doi: 10.1093/ntr/ntu279
19. Manseau, M. W., and Goff, D. C. (2015). Cannabinoids and Schizophrenia: risks and therapeutic potential. Neurotherapeutics 12, 816-824. doi: 10.1007/s13311-015-0382-6
20. Pagano, T., DiFrancesco, A. G., Smith, S. B., George, J., Wink, G., Rahman, I., et al. (2015). Determination of nicotine content and delivery in disposable electronic cigarettes available in the united states by gas chromatography-mass spectrometry. Nicotine Tob. Res. 18, 700-707. doi: 10.1093/ntr/ntv120
21. Peace, M. R., Baird, T. R., Smith, N., Wolf, C. E., Poklis, J. L., and Poklis, A. (2016a). Concentration of nicotine and glycols in 27 electronic cigarette formulations. J. Anal. Toxicol. 40, 403-407. doi: 10.1093/jat/bkw037
22. Peace, M. R., Stone, J. W., Poklis, J. L., Turner, J. B. M., and Poklis, A. (2016b). Analysis of a commerical marijuana e-cigarette formulation. J. Anal. Toxicol. 40, 374-378. doi: 10.1093/jat/bkw021
23. Poklis, J. L., Raso, S. A., Alford, K. N., Poklis, A., and Peace, M. R. (2015a). Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine derivatives on blotter paper. J. Anal. Toxicol. 39, 617-623. doi: 10.1093/jat/bkv073
24. Poklis, J. L., Thompson, C. C., Long, K. A., Lichtman, A. H., and Poklis, A. (2010). Disposition of cannabichromene, cannabidiol, and δ?-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 8, 516-520. doi: 10.1093/jat/34.8.516
25. Poklis, J. L., Wolf, C. E., ElJordi, O. I., Liu, K., Zhang, S., and Poklis, A. (2015b). Analysis of the first-and second-generation raving dragon novelty bath salts containing methylone and pentedrone. J. Forensic Sci. 60, S234-S240. doi: 10.1111/1556-4029.12629
26. Trehy, M. L., Ye, W., Hadwiger, M. E., Moore, T. W., Allgire, J. F., Woodruff, J. T., et al. (2011). Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J. Liq. Chromatogr. Relat. Technol. 34, 1442-1458. doi: 10.1093/ntr/ntu197
27. U.S. Food and Drug Administration [FDA] (2016). "FDA Takes Significant Steps to Protect Americans From Dangers of Tobacco Through New Regulation," fda.gov, Last Modified May 10, 2016. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm499234.htm [accessed May 12, 2016].
28. United States Drug Enforcement Administration [DEA] (2016). "DEA Eases Requirements for FDA-Approved Clinical Trials on Cannabidiol," dea.gov, last modified December 23, 2015. Available at: http://www.dea.gov/divisions/hq/2015/hq122315.shtml [accessed May 12, 2016].
29. United States Food and Drug Administration (2015a). Gas Chromatography-Mass Spectrometry (GC-MS) Screening Procedure for the Presence of Diethylene Glycol and Ethylene Glycol in Toothpaste. Available at: http://www.fda.gov/Food/FoodScienceResearch/LaboratoryMethods/ucm113209.htm [accessed October 16, 2014].
30. United States Food and Drug Administration (2015b). Warning Letters and Test Results," fda.gov, last Modified February 9, 2015. Available at: http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm435591.htm [accessed May 12, 2016].
31. Varlet, V., Concha-Lozano, N., Berthet, A., Plateel, G., Favrat, B., De Cesare, M., et al. (2016). Drug vaping applied to cannabis: is "Cannavaping" a therapeutic alternative to marijuana? Nature 6, 25599. doi: 10.1038/srep25599
32. Watson, C. H., Trommel, J. S., and Ashley, D. L. (2004). Solid-phase microextraction-based approach to determine free-base nicotine in trapped mainstream cigarette smoke total particulate matter. J. Agric. Food Chem. 52, 7240-7245. doi: 10.1021/jf049455o
33. Wu, W., Ashley, D. L., and Watson, C. H. (2002). Determination of nicotine and other minor alkaloids in international cigarettes by solid-phase microextraction and gas chromatography/mass spectrometry. Anal. Chem. 74, 4878-4884. doi: 10.1021/ac020291p
34. Ye, Q. (2008). Development of solid-phase microextraction followed by gas chromatography-mass spectrometry for rapid analysis of volatile organic chemicals in mainstream cigarette smoke. J. Chromatography. A 1213, 239-244. doi: 10.1016/j.chroma.2008.10.063